Ajanta Pharma Limited — Important, 30-04-2025: General Updates

Ajanta Pharma Limited's Nomination and Remuneration Committee has approved the cancellation of 1,000 stock options from its Share Based Incentive Plan, returning these options to the ESOP pool for potential reallocation or new grants. This decision may influence employee retention strategies, though short-term financial implications are expected to be negligible.